West Pharmaceutical Services Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| 28.3 | 11.1 | 87.9 | 12.0 | 221.5 | – | 19.2 | 15.5 | 39.7 | 17.8 | 25.6 | 20.8 | 15.9 | 19.6 | 23.2 | 18.6 | 24.4 | 31.2 | 30.5 | 46.5 | 44.3 | 49.6 | 35.7 | 46.9 | 62.0 | 54.1 | 30.5 | 44.7 | 49.0 | 40.5 | |
| 1.0 | 1.1 | 1.3 | 1.0 | 0.8 | 1.0 | 0.8 | 1.0 | 1.4 | 1.2 | 1.9 | 1.4 | 1.3 | 1.3 | 1.4 | 1.2 | 1.6 | 2.6 | 2.7 | 3.2 | 4.2 | 4.7 | 4.3 | 6.1 | 10.0 | 12.6 | 6.2 | 9.0 | 8.3 | 6.5 | |
| 1.8 | 1.8 | 2.6 | 2.0 | 1.7 | 2.2 | 1.7 | 1.9 | 2.6 | 2.4 | 4.2 | 3.0 | 2.8 | 2.5 | 2.4 | 2.1 | 2.7 | 3.9 | 4.0 | 4.3 | 5.7 | 4.5 | 5.3 | 7.2 | 11.6 | 15.3 | 6.6 | 9.2 | 9.0 | 6.3 | |
| 1.0 | 1.0 | 1.3 | 1.0 | 1.2 | 1.3 | 1.2 | 1.3 | 1.6 | 1.5 | 2.1 | 1.7 | 1.6 | 1.6 | 1.6 | 1.4 | 1.8 | 2.7 | 2.8 | 3.2 | 4.2 | 4.7 | 4.2 | 6.1 | 9.8 | 12.5 | 6.0 | 8.8 | 8.3 | 6.3 | |
| 5.2 | 4.7 | 6.1 | 4.4 | 6.7 | 7.1 | 6.0 | 7.4 | 9.1 | 8.5 | 12.7 | 11.2 | 8.9 | 10.3 | 10.9 | 9.1 | 11.1 | 14.7 | 14.5 | 20.4 | 22.2 | 23.2 | 20.5 | 27.7 | 40.7 | 40.1 | 21.3 | 30.7 | 32.1 | 26.9 | |
| 14.7 | 14.8 | – | 77.5 | – | – | 21.8 | 58.7 | 67.0 | 25.8 | 32.2 | – | – | 47.6 | 23.4 | 41.5 | 35.5 | 54.2 | 54.7 | 55.0 | 129.3 | 56.5 | 40.2 | 47.1 | 72.0 | 108.2 | 40.6 | 64.0 | 87.4 | 42.7 | |
| 6.8% | 6.7% | -1.0% | 1.3% | -2.5% | -3.0% | 4.6% | 1.7% | 1.5% | 3.9% | 3.1% | 0.0% | -0.3% | 2.1% | 4.3% | 2.4% | 2.8% | 1.8% | 1.8% | 1.8% | 0.8% | 1.8% | 2.5% | 2.1% | 1.4% | 0.9% | 2.5% | 1.6% | 1.1% | 2.3% | |
| Margins | ||||||||||||||||||||||||||||||
| 34.2% | 36.2% | 37.2% | 38.4% | 32.6% | 29.3% | 28.0% | 31.8% | 30.9% | 27.7% | 28.7% | 28.6% | 28.8% | 28.8% | 28.7% | 28.4% | 30.6% | 31.8% | 31.5% | 32.6% | 33.2% | 32.1% | 31.8% | 33.0% | 35.8% | 41.5% | 39.5% | 38.4% | 34.6% | 35.9% | |
| 11.6% | 13.7% | 14.4% | 14.2% | 8.3% | 10.4% | 6.4% | 11.1% | 11.8% | 10.5% | 11.6% | 11.1% | 11.9% | 10.0% | 9.6% | 9.7% | 10.8% | 11.9% | 12.8% | 9.2% | 13.0% | 14.3% | 14.8% | 16.1% | 19.5% | 26.8% | 26.5% | 24.1% | 20.6% | 20.1% | |
| 3.6% | 9.8% | 1.5% | 8.2% | 0.4% | -1.3% | 4.4% | 6.5% | 3.6% | 6.5% | 7.3% | 6.9% | 8.2% | 6.9% | 5.9% | 6.3% | 6.4% | 8.2% | 8.9% | 6.8% | 9.5% | 9.4% | 12.0% | 13.1% | 16.1% | 23.4% | 20.3% | 20.1% | 17.0% | 16.1% | |
| 6.9% | 7.4% | -1.3% | 1.3% | -2.0% | -2.9% | 3.9% | 1.7% | 2.1% | 4.5% | 5.9% | 0.0% | -0.4% | 2.8% | 5.8% | 2.8% | 4.4% | 4.7% | 5.0% | 5.8% | 3.3% | 8.3% | 10.7% | 13.1% | 13.9% | 11.7% | 15.2% | 14.0% | 9.6% | 15.3% | |
| Returns | ||||||||||||||||||||||||||||||
| 6.5% | 16.0% | 2.9% | 16.7% | 0.8% | -2.9% | 9.1% | 12.4% | 6.4% | 13.7% | 16.2% | 14.6% | 17.7% | 12.5% | 10.4% | 11.5% | 11.1% | 12.4% | 13.3% | 9.3% | 12.9% | 9.0% | 14.8% | 15.4% | 18.7% | 28.3% | 21.8% | 20.6% | 18.4% | 15.5% | |
| 3.4% | 9.3% | 1.3% | 7.0% | 0.3% | -1.0% | 3.4% | 5.1% | 2.9% | 5.5% | 7.3% | 6.0% | 7.4% | 5.7% | 5.0% | 5.4% | 5.2% | 6.7% | 7.6% | 5.6% | 8.4% | 8.1% | 13.0% | 10.3% | 12.4% | 20.0% | 16.2% | 15.5% | 13.5% | 11.6% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| -25 | -51 | 4.8 | -16 | 157 | 151 | 142 | 137 | 92 | 232 | 189 | 287 | 299 | 297 | 248 | 258 | 250 | 144 | 81 | 24 | 26 | 64 | -141 | -172 | -350 | -500 | -669 | -629 | -263 | -566 | |
| -0.3 | -0.5 | 0.0 | -0.2 | 2.1 | 2.0 | 1.7 | 1.6 | 1.0 | 1.9 | 1.3 | 1.8 | 1.6 | 1.8 | 1.5 | 1.4 | 1.2 | 0.6 | 0.3 | 0.1 | 0.1 | 0.2 | -0.4 | -0.4 | -0.7 | -0.6 | -0.8 | -0.7 | -0.4 | -0.8 | |
| 52.8% | 58.1% | 45.5% | 41.9% | 36.7% | 34.6% | 37.5% | 41.3% | 45.7% | 40.5% | 45.1% | 40.9% | 41.7% | 45.6% | 48.3% | 46.8% | 46.6% | 54.2% | 57.3% | 60.4% | 65.1% | 89.4% | 87.7% | 67.2% | 66.4% | 70.5% | 74.2% | 75.2% | 73.6% | 74.4% | |
| 0.0 | 0.0 | 0.2 | 0.1 | 1.0 | 1.1 | 0.9 | 0.7 | 0.5 | 0.8 | 0.6 | 0.8 | 0.8 | 0.7 | 0.6 | 0.5 | 0.6 | 0.4 | 0.4 | 0.3 | 0.2 | 0.2 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Per Share | ||||||||||||||||||||||||||||||
| 0.25 | 0.67 | 0.10 | 0.64 | 0.03 | -0.09 | 0.32 | 0.55 | 0.31 | 0.70 | 1.00 | 0.98 | 1.19 | 1.00 | 0.89 | 1.02 | 1.12 | 1.57 | 1.75 | 1.30 | 1.91 | 1.99 | 2.74 | 3.21 | 4.57 | 8.67 | 7.73 | 7.88 | 6.69 | 6.79 | |
| 6.99 | 6.83 | 6.81 | 7.79 | 7.46 | 6.92 | 7.26 | 8.43 | 8.79 | 10.76 | 13.59 | 14.09 | 14.56 | 14.54 | 15.05 | 16.12 | 17.64 | 19.17 | 19.52 | 18.97 | 20.12 | 21.10 | 22.79 | 24.45 | 28.32 | 37.10 | 38.07 | 39.19 | 39.25 | 42.28 | |
| 3.84 | 4.19 | 3.49 | 3.84 | 3.55 | 3.08 | 3.49 | 4.43 | 4.89 | 5.13 | 6.17 | 6.70 | 6.75 | 7.98 | 8.52 | 8.85 | 10.15 | 12.69 | 13.14 | 13.87 | 14.90 | 21.98 | 18.52 | 20.86 | 24.47 | 30.61 | 35.42 | 38.26 | 36.39 | 43.69 | |
| 0.48 | 0.50 | -0.09 | 0.10 | -0.15 | -0.20 | 0.28 | 0.14 | 0.19 | 0.48 | 0.80 | 0.00 | -0.06 | 0.41 | 0.88 | 0.46 | 0.77 | 0.91 | 0.97 | 1.09 | 0.66 | 1.75 | 2.44 | 3.19 | 3.93 | 4.33 | 5.80 | 5.50 | 3.75 | 6.45 | |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.